A Proof of Concept Clinical Trial of the Combination Cediranib-Olaparib at the Time of Disease Progression on Olaparib in Ovarian Cancer
This is a phase 2 study (the second phase in testing a new drug or drug combination) to see
how useful adding investigational drug cediranib to olaparib after disease progression on
olaparib alone in patients with ovarian cancer.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society